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1. Introduction 
Nicotinic acetylcholine receptors (AchR) from 
various vertebrate organisms have been intensively 
investigated because of their significance for the 
control of ion permeability within the process of 
synaptic transmission [ 1,2]. 
The presence of a nicotinic choline@ system in 
the central nervous system of insects, although not 
yet conclusively demonstrated, is strongly supported 
by a series of findings: (i) Mutants for two metabolic 
enzymes of acetylcholine, choline acetyltransferase 
and acetylcholine esterase, produce neuroanatomical, 
electrophysiological and behavioural defects in 
Drosophila melanogaster [3]. (ii) a-Bungarotoxin 
(aBgt), a specific ligand for the nicotinic AChRs of 
vertebrates, binds to a component present in heads of 
Drosophila melanogaster [4-71 and Musca domestica 
[ 51, in brain tissue of the moth Manduca sexta [8] 
and in abdominal nerve cords of Periplaneta ameri- 
cana [9]. The binding fulfils the criteria of satura- 
bility , pharmacological specificity and tissue localiza- 
tion, as required for a nicotinic AChR [4-71. 
(iii) Electrophysiological evidence corroborates the 
biochemical and pharmacological studies. cwBgt blocks 
transmission at the central-nerve giant-fiber synapses 
in the terminal abdominal ganglion of Periplaneta 
[9]. This blockage is also exerted by isothiocyanate 
and nicotine at concentrations similar to those re- 
quired for the inhibition of the [12’I]cuBgt binding to 
extracts from Periplaneta and Drosophila 191. These 
findings make it very plausible to assume the exis- 
tence of cholinergic synapses in the central nervous 
Abbreviations: AChR, acetylcholine receptor; &Bgt, a-bun- 
garotoxin; [1Z51]aBgt, [ lZSI,]diiodo~-bungarotoxin 
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system of insects and to regard the aBgt binding 
component as a putative nicotinic AChR. 
The characterization of the AChR in Drosophila 
is of phylogenetic interest in the study of its evolu- 
tionary stability. Moreover, it offers a possibility to 
approach to the genetic dissection of the synaptic 
process of ion permeability control, since Drosophila 
enables the application of powerful genetic techni- 
ques to the isolation of mutants in this system. 
A requisite for the analysis of AChR mutants is 
the biochemical characterization of the wild-type 
receptor. Furthermore, the demonstration of a bio- 
chemical similarity between the well-studied AChRs 
of vertebrates and that of Drosophila would prove it 
to be an appropriate model system. 
We here report the solubilization of the putative 
AChR of Drosophila and some of its biochemical and 
pharmacological properties, using [ 12’I]aBgt as a 
specific, high-affinity ligand. From our results we 
conclude that Drosophila may be used as an 
appropriate model for studies of the function of the 
AChR. 
2. Materials and methods 
Heads of Drosophila (wild-type strain ‘Oregon R’) 
were harvested according to the technique of Harris 
et al. [lo], and homogenized in 130 mM NaCl, 5 mM 
KCl, 3 mM EDTA, 20 mM Tris-HCl, pH 7.8 
(buffered Drosophila-Ringer) at a concentration of 
800 heads/ml. Homogenization was performed on ice 
in a Biihler blender homogenizer for 3 X 30 s at 
maximum speed. The homogenate was freed of 
cuticle particles by filtration through a nylon cloth 
(pore size 60 ,um) and centrifuged for 5 min at 
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800 X g. The pellet was resuspended in homogeniza- 
tion buffer and centrifuged again. The collected 
supernatants were further centrifuged on a cushion of 
35% sucrose in homogenization buffer at 30 000 X g 
for 25 min. Most of the crBgt binding activity was 
found in the interphase between sucrose solution and 
su~rnatant, The pellet of this centrifugation contain- 
ed the eye screening pigment; it was found to contain 
no arBgt binding activity. The interphase was collect- 
ed, diluted with homogenization buffer and centri- 
fuged at 40 000 X g for 25 min. The pellet (‘interphase 
pellet’} was used for the following expe~ments. 
The interphase pellet was resuspended to a final 
concentration of 5-10 mg protein/ml in 50 mM 
NaCl, 50 mM Tris, containing 1 mg/ml phenyl- 
methylsulfonyl f uoride (PMSF) and 10 pg/ml Pep- 
statin as protease inhibitors, and the pH adjusted with 
HCI to the value to be tested for solub~ization ef- 
ficiency. After addition of detergent to a final con- 
centration of l%, the mixture was incubated for 
30 min at 25°C and afterwards centrifuged for 1 h at 
100 000 X g. The following conditions were chosen 
as a standard solub~ization procedure (see section 3): 
Incubation in 100 mM NaCI, 1 mM EDTA, 1% so- 
dium deoxycholate, 10 mM Tris-HCl, pH 8.7, at 
25’C for 30 min followed by the above-mentioned 
centrifugation. The supernatant isreferred to as 
‘soluble xtract’. 
[‘251]aBgt with a specific activity of 500-700 
Cifmmole was prepared according to the method of 
Vogel et al. [ 1 I]. It was further purified from radio- 
active contaminants on a 1 ml DEAE-cellulose 
column to minimize unspecific binding to the DEAE- 
cellulose filters used in the assay of solubilized 
material. 
Binding assays were performed under saturating 
conditions (10 nM [“‘I]aBgt, 0.1-l nM AChR), 
unless otherwise stated, in a total volume of 50 /.d 
in 50 mM NaCI, 1 mM EDTA, 10 mM Tris-HCl, 
pH 7.5, (incubation buffer) and, addition~ly, 1 mM 
nicotine to measure unspecific binding and 1% 
Triton X-100 when testing soluble receptor. After 
incubation at 25*C for 90 min, unless otherwise 
indicated, the samples were diluted with 0.2 ml of 
incubation buffer and filtered. [*251]&Bgt receptor 
complex was retained on Sartorius SM 11107 cellu- 
lose acetate filters (in the case of membranes} or on 
Whatman DE 81 DEAEcellulose filters (in the 
case of solubilized material) and washed twice with 
3 ml of incubation buffer. Filters were then dried 
184 
and radioactivity determined in 0.5% PPO/toluene. 
0.2 ml of soluble extract, supplemented with p- 
galactosidase (E. coli, grade IV), catalase (beef liver), 
cytochrome c (horse heart) and blue dextran, were 
filtered through a 30 ml Sepharose 6B column, which 
had been equ~ibrated with 100 mM NaCl, I mM 
EDTA, 1% Triton X-l 00,lO mM Tris-HCl, pH 8.0 
at 4”C, and fractions of 0.7 ml were collected. 
/I-Galactosidase and catalase were assayed as described 
in [ 121 and [13], respectively. [1251]crBgt binding 
activity was measured using the DEAEcellulose filter 
technique. 
0.2 ml of soluble extract were centrifuged on a 
5-20% sucrose gradient in the same buffer plus 
marker proteins, as used for Sepharose 6B gel 
filtration for 3.5 h at 60 000 rev./min in a Beck- 
mann SW 65 rotor at 2O*C. Fractions of 140 pi 
were collected and aliquots assayed as described 
above. 
Protein concentrations were measured as described 
by Lowry et al. [ 141, using bovine serum albumin as 
a standard. Prior to spectrophotometry, samples con- 
taining Triton X-100 were cent~fuged in a Beckmann 
Microfuge B to eliminate the precipitate produced in 
the presence of the detergent. 
3. Results and discussion 
Synaptic membranes of Dr~sop~j~~ seem to be 
very resistant against extraction by detergents. Dudai 
reported [6] that Triton X-100, which yields quanti- 
tative solubihzation of the AChR from vertebrates 
[ 151, is only sli~tly effective in the case of Droso- 
~~jZff AChR. It was shown [6] that the T&on ‘sdu- 
bilized’ receptor, as judged by centrifugation at 
100 000 X g for 1 h, sedimented at higher forces and 
longer times, and appeared as complexes of high 
molecular weight upon gel filtration. Taking centrifu- 
gation as a provisional criterion, we find (table 1) 
that, by increasing the pH, the solubilization of the 
Drosophila AChR achieved with Triton X-I 00 is 
improved. Moreover, extraction with deoxycholate 
turns out to be more efficient than that with Triton 
X-100, and also exhibiting the same pH dependency. 
A combination of both detergents does not increase 
the yield of soluble AChR. In the experiment shown 
in Table 1 the improvement of receptor solubilization 
runs in parallel with an increase of the specific recep- 
tor concentration i  the soluble fraction. This result 
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Table 1 
Solubilization efficiency with two detergents and various pH-values 
Solubilization Receptor Protein Specific receptor % 
conditions concentration content concentration Solubilization 
WI) (mglml) (pmoli”mg) 
‘Interphase’ (not treated) 5.9 4.25 1.39 100 
1% Triton X-100 pH 7.5 0.6 1.85 0.32 10 
1% Triton X-100 pH 8.1 0.9 1.90 0.49 16 
1% Triton X-100 pH 9.0 1.5 1.95 0.77 25 
1% Sodium deoxycholate pH 8.1 2.0 2.80 0.71 34 
1% Sodium deoxycholate pH 9.0 2.9 2.45 I.18 49 
1% Triton X-100 + 
1% Sodium deoxycholate pH 9.0 2.9 2.50 1.16 49 
For details of solubilization procedure and binding assay see section 2. [ ‘z51]orBgt binding activity 
was compared in aliquots of the material not treated with detergents (‘interphase’) and the super- 
natants of the cen~ifugation at 100 000 X g for 1 h after various detergent reatments. % solubili- 
zation’ means the fraction of AChR concentration found in the supernatants as compared to the 
interphase 
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suggests hat the AChR of Drosophila is more re- 
sistant o soiubilization than other membrane pro- 
teins. A substantial fraction of the receptor extracted 
with 1% deoxycholate at pH 9.0 can be regarded as 
really solubilized, as shown by its inclusion in a 
Sepharose 6B column (fig.lA). Thus, we conclude, 
that experimental conditions bringing a reasonable 
fraction of the AChR into a soluble state have been 
Froctlon Number 
F&l. Estimation of the molecular weight of the AChR 
complex by (A) gel filtration on Sepharose 6B and (B) su- 
crose density gradient. For experimental details see section 2. 
w, void volume; @Cal, pgalactosidase; Cat, cat&se; Cyt C, 
cytochrome c. a, [ “‘IjruBgt bound specifically to 50 nl ali- 
quots of the fractions; o, enzyme activity in aliquots of the 
fractions, represented in arbitrary units. 
established, allowing us to proceed with further steps 
towards its total pu~~cation. 
Equ~ib~um (luD) and kinetic constants are diffl- 
cult to compare between different reports, because 
the K, is highly dependent on the content of cations 
such as Na+, K+, NH: or Tris’ in the incubation mix- 
ture, probably due to a competitive binding of these 
ions to the oBgt binding site ]16,17]. Therefore it is 
necessary to give a measured lu, as an apparent 
value and to specify exactly the conditions of the 
experiment. Table 2 shows kinetic and equilibrium 
constants, measured under identical conditions for 
the receptor in the membrane bound as well as in the 
soluble state. It turns out that solub~ization does not 
alter the physicochemical properties of the AChR for 
the binding with [‘251](uBgt. Furthermore, KDs agree 
well with each other when determined by kinetic 
and equilibrium measurements. The KD values are 
close to those reported for the binding of cu-neuro- 
toxins to the AChR of EIec~opho~s [ 181, rat dia- 
phragm [21] and the putative AChR from rat brain 
[ 15 ,19,20], assuming a similar dependency of o-toxin 
binding upon small cation concentrations in these 
systems [171 as was found in Drosophila for cvBgt 
binding [16]. The dissociation constant we found 
for the AChR-cuBgt complex in ~oso~h~~a is about 
1 O-SO times higher than those found in electric 
organs and in the vertebrate neuromuscular junction, 
but is in the same range as the dissociation constants 
185 
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Table 2 
Kinetic and equilibrium constants of the [‘*‘I]orBgt receptor binding reaction 
May 1980 
State of receptor k,, (on-rate) k_, (off- KD from equilibrium 
(M-' s-r) rate) (s-l) measurements 
(M) 
Membrane bound 5.5 .I O5 1.7 . 1o-5 1.4. lo-I0 1.6 (kO.3). lo-“’ 
Soluble state 4.6 . 10’ 8.3. lo-’ 1.8. 10-r’ 2.3 (tO.6) . lo-lo 
On-rate kinetics were measured as described for the [ “‘I]orBgt binding assay (AChR concentra- 
tion -1 nM). The reactions were stopped by addition of 0.2 ml of 1 mM nicotine at the appro- 
priate times. The reaction rate within the first 4 min was taken as the basis for calculation of 
the kinetic constant. Off-rate kinetics were started by addition of non-labelled oBgt to a final 
concentration of 1 PM after 45 min of preincubation of the material in 10 nM [r2’I]orBgt. 
KDs were also derived from equilibrium measurements using Scatchard plot analysis with 
olBgt concentrations between 10 pM and 10 nM and an incubation time of 60 min 
found in some instances for the putative AChR from 
rat brain [ 15,19,20]. In this latter case, values ranging 
from 5.8. lo-’ s-’ [19] to 3.1 . 10m6 s-l [20] 
have been reported, the discrepancies being attributed 
to variation in experimental conditions [20]. Similar 
considerations might also explain the different disso- 
ciation constants obtained for Drosophila. Whereas 
those reported here and by Dudai [6] are similar, 
Schmidt-Nielsen et al. [4] found the receptor-toxin 
complex to be practically irreversible. It seems as if 
the determination of these parameters were 
particularly sensitive to experimental modifications in 
the case of AChRs from central nervous systems. 
In vertebrates various drugs are known to be either 
agonists or antagonists of the neurophysiological 
effect of acetylcholine on various types of AChRs. 
Table 3 summarizes the inhibitory effects of some of 
these drugs on the binding rate of [ 1251]cYBgt to 
membrane bound and soluble AChR. High affinities 
are found for all nicotinic ligands tested, suggesting 
that the aBgt binding site is a nicotinic AChR. The 
affinity of atropine for this putative AChR turns out 
to be higher than that for nicotinic AChRs in verte- 
brates, but still much lower than that of all nicotinic 
ligands tested in Drosophila excepting carbamyl- 
choline, which is known to be a rather weak agonist. 
Furthermore Dudai reported a much higher affinity 
of atropine (Kl = 4 nM) to a putative muscarinic 
Table 3 
Inhibition by various cholinergic ligands of the rate of [ ‘251]olBgt binding 
reaction 
Type of inhibitor Inhibitor IC,, (PM) 
Membrane bound Soluble state 
Nicotinic agonists Carbamylcholine 60 70 
Nicotine 1.0 0.8 
Nicotinic antagonists d-Turbocurarine 2.4 2.1 
Flaxedil 5.5 6.3 
Muscarinic agonist Muscarine 1500 1000 
Muscarinic antagonist Atropine 25 100 
The reaction was started by addition of [‘ZSI]cyBgt (10 nM) after 30 min preincu- 
bation in the presence of various concentrations of inhibitor, and stopped after 
3 min by the addition of 0.2 ml 1 mM nicotine. IC,, is the concentration of 
inhibitor necessary to reduce on-rate reaction to 50% of the value without inhibi- 
tor. ‘Membrane bound’ refers to the interphase pellet, ‘soluble state’ to material 
coeluting with pgalactosidase (see fig.lA) in gel filtration 
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AChR of Drosophila [ 221. Thus the rather high 
affinity of atropine for the putative AChR described 
here does not justify to classify it as a muscarinic or 
mixed nicotinic/muscarinic one. In electric fishes 
the affinity for cholinergic antagonists remains stable 
upon solubilization, whereas the affinity for agonists 
increases in Electrophoms [23] and decreases in 
Torpedo [24-261. These results have been interpret- 
ed assuming that the receptor is present under 
different states of affinity and that extraction by 
detergents may cause an interconversion between 
these states [24-261. The fact that in Drosophila 
solubilization does not change the affinity either 
for agonists and antagonists (Table 3) might mean 
that the AChR does not exist under different states 
of affinity. However, the finding of negative 
cooperativity in the inhibition by acetylcholine of 
the cuBgt binding to the membrane-bound receptor 
[7] suggests that such a heterogeneity of affinity 
states does exist. 
Slightly different results for the affinity of the 
soluble receptor for antagonists have recently been 
reported by us [ 161, but crude extract was used in 
those studies instead of the more pure fraction 
(receptor coeluting with /I-galactosidase in gel filtra- 
tion) used here. Acetylcholine and/or other unknown 
ligands of the AChR might reduce, due to competi- 
tive interaction, the apparent affinity for agonists 
when assaying the crude fraction. 
Determination of the apparent molecular weight 
of the soluble native AChR provides very similar 
values to those reported for Electrophorus [ 131 and 
the putative AChR from rat brain [ 151. Fig.lA shows 
that part of the deoxycholate extracted material 
(GO% of total binding activity) eluted with the 
void volume in gel filtration. This can be interpreted 
as either high molecular weight membrane particles 
due to incomplete solubilization or to re-aggregation 
of soluble material. Apart from this high molecular 
weight fraction a considerable amount of the binding 
activity elutes together with /I-galactosidase 
(420 000 MW) upon gel filtration and co-sediments 
with catalase (250 000 MW) in sucrose gradient 
centrifugation. These hydrodynamic properties are in 
exact agreement with those reported for the AChR 
from Electrophoms [ 131 and the putative AChR 
from rat brain [ 151. Another fraction of higher molec- 
ular weight (fig.lA, fract. 23; fig.lB, fract. 12), 
which exhibits binding activity, is also found and may 
represent dimers of the receptor complex. 
The results presented here indicate that the puta- 
tive nicotinic AChR of Drosophila exhibits several 
biochemical properties similar to those of the AChR 
from vertebrates, suggesting a rather high evolution- 
ary stability. Therefore we conclude that Drosophila 
may be used as an appropriate model for studies on 
the function of the AChR system. The first steps to- 
wards a genetic dissection of the system have been 
made with the recent description of genetic variants 
that affect AChR structure [27]. 
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